Showing 81-100 of 753 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Antiepileptic drugs for the primary and secondary prevention of seizures after intracranial venous thrombosis
Cochrane Systematic Reviews, 25-Jul-2014
Intracranial venous thrombosis (ICVT) commonly presents with seizures in the acute period, and some people may develop recurrent seizures in the long term. The prophylactic use of antiepileptic drugs (AEDs) for the management of post-ICVT seizures is cont
- Antiepileptics for aggression and associated impulsivity
Cochrane Systematic Reviews, 17-Jan-2010
Aggression is a major public health issue and is integral to several mental health disorders. Antiepileptic drugs may reduce aggression by acting on the central nervous system to reduce neuronal hyper-excitability associated with aggression.
- Antifibrinolytics for heavy menstrual bleeding
Cochrane Systematic Reviews, 20-Sep-2010
Heavy menstrual bleeding (HMB) is an important cause of ill health in women. Medical therapy, with the avoidance of possibly unnecessary surgery, is an attractive treatment option. A wide variety of medications are available to reduce heavy menstrual blee
- Antifungal agents for preventing fungal infections in non-neutropenic critically ill patients
Cochrane Systematic Reviews, 15-Jan-2016
Invasive fungal infections are important causes of morbidity and mortality among critically ill patients. Early institution of antifungal therapy is pivotal for mortality reduction. Starting a targeted antifungal therapy after culture positivity and fungi
- Antifungal agents for preventing fungal infections in solid organ transplant recipients
Cochrane Systematic Reviews, 12-May-2009
Invasive fungal infections (IFIs) are important causes of morbidity and mortality in solid organ transplant recipients.
- Antifungal interventions for the primary prevention of cryptococcal disease in adults with HIV
Cochrane Systematic Reviews, 10-Nov-2008
Cryptococcal disease is an opportunistic infection that causes significant morbidity and mortality in adults with HIV. Primary prophylaxis with antifungal interventions may decrease cryptococcal disease incidence and associated mortality.
- Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis
Cochrane Systematic Reviews, 2-Sep-2022
Allergic bronchopulmonary aspergillosis (ABPA) is an allergic reaction to colonisation of the lungs with the fungus Aspergillus fumigatus, and affects around 10% of people with cystic fibrosis. ABPA is associated with an accelerated decline in lung functi
- Antifungal therapy for newborn infants with invasive fungal infection
Cochrane Systematic Reviews, 15-May-2012
A variety of antifungal drugs, drug preparations and drug combinations are available to treat newborn infants with suspected or confirmed invasive fungal infection. There is a need to assess their relative merits.
- Antihistamines and/or decongestants for otitis media with effusion (OME) in children
Cochrane Systematic Reviews, 18-Jul-2011
This is an update of a Cochrane Review first published in The Cochrane Library in Issue 4, 2006.
- Anti-histamines for prolonged non-specific cough in children
Cochrane Systematic Reviews, 19-Nov-2009
Non-specific cough is defined as non-productive cough in the absence of identifiable respiratory disease or known aetiology. It is commonly seen in paediatric practice. These children are treated with a variety of therapies including anti-histamines. Also
- Antihistamines for the common cold
Cochrane Systematic Reviews, 21-Jul-2009
Although antihistamines are prescribed in large quantities for the common cold, there is little evidence as to whether these drugs are effective.
- Antihypertensive agents for preventing diabetic kidney disease
Cochrane Systematic Reviews, 20-Aug-2013
Various blood pressure-lowering agents, and particularly inhibitors of the renin-angiotensin system (RAS), are widely used for people with diabetes to prevent the onset of diabetic kidney disease (DKD) and adverse cardiovascular outcomes. This is an updat
- Antihypertensive treatment for kidney transplant recipients
Cochrane Systematic Reviews, 29-Nov-2009
In some nontransplant populations, effects of different antihypertensive drug classes vary. Relative effects in kidney transplant recipients are uncertain.
- Anti-inflammatory drugs and analgesics for managing symptoms in people with cystic fibrosis-related arthritis
Cochrane Systematic Reviews, 21-Jan-2016
Arthritis remains a relatively infrequent complication of cystic fibrosis, but is a cause of significant morbidity when it does occur. Two distinct types of arthritis are described in cystic fibrosis: cystic fibrosis-related arthropathy (CFA) and hypertro
- Anti-inflammatory treatment for carditis in acute rheumatic fever
Cochrane Systematic Reviews, 28-May-2015
Rheumatic heart disease remains an important cause of acquired heart disease in developing countries. Although prevention of rheumatic fever and management of recurrences have been well established, optimal management of active rheumatic carditis remains
- Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
Cochrane Systematic Reviews, 8-Dec-2014
Anti-leukotrienes (5-lipoxygenase inhibitors and leukotriene receptors antagonists) serve as alternative monotherapy to inhaled corticosteroids (ICS) in the management of recurrent and/or chronic asthma in adults and children.
- Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis
Cochrane Systematic Reviews, 22-Sep-2008
Non-alcoholic fatty liver disease (NAFLD) is characterised by fatty deposition in the hepatocytes of patients with minimal or no alcohol intake and without other known cause. NAFLD includes a wide spectrum of histologic abnormalities ranging from hepatic
- Antioxidant supplements for preventing gastrointestinal cancers
Cochrane Systematic Reviews, 25-May-2008
Oxidative stress may cause gastrointestinal cancers. The evidence on whether antioxidant supplements are effective in preventing gastrointestinal cancers is contradictory.
- Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases
Cochrane Systematic Reviews, 14-Mar-2012
Our systematic review has demonstrated that antioxidant supplements may increase mortality. We have now updated this review.
- Antioxidant treatment for amyotrophic lateral sclerosis or motor neuron disease
Cochrane Systematic Reviews, 10-May-2011
Free radical accumulation and oxidative stress have been proposed as contributing to the progression of amyotrophic lateral sclerosis (or motor neuron disease). A range of antioxidant medications have been studied. This is an updated review.
